Disitamab vedotin

CAT: 1410-M35132-01Size: 1 gDry Ice: NoHazardous: No
CAT#:1410-M35132-01Size:1 g
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Disitamab vedotin (RC-48) is a newly developed antibody-active molecule conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), consisting of hertuzumab coupled to monomethyl auristatin E (MMAE) via a cleavable linker. Disitamab vedotin showed anti-tumor and anti-proliferative activities in gastric cancer cells with different HER-2 expression levels and inhibited the expression of HER-2 protein in gastric cancer cells.
CAS Number
2136633-23-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 144.15 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antibody-Drug Conjugates (ADCs) | EGFR

Popular Products